Physician profile
Theodore A Ruff
NPI 1477529139
$727.58
in general payments reported to CMS, 2019-2025
12 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.43 · 2020: $128 · 2022: $66.30 · 2023: $122 · 2024: $173 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $216.93 | 2022-2025 | Signia, Absorbatack |
| Allergan, INC. | $127.64 | 2020 | |
| Davol INC. | $103.72 | 2022-2025 | Phasix Mesh |
| Tela Bio, INC. | $80.54 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Stryker Corporation | $47.62 | 2025 | 1788 |
| Teleflex LLC | $34.72 | 2025 | Deknatel |
| Integra Lifesciences Corporation | $26.26 | 2022 | |
| Innovation Technologies INC | $25.21 | 2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $22.33 | 2025 | Exparel |
| Braintree Laboratories, INC. | $19.53 | 2023 | Suflave, Sutab |
| Merck Sharp & Dohme LLC | $12.43 | 2019 | |
| Levita Magnetics International Corp. | $10.65 | 2024 | Toothed Grasper, Magnetic Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Ruff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.